VolitionRx Limited (NYSEAMERICAN:VNRX – Get Free Report)’s share price crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.00 and traded as high as $0.62. VolitionRx shares last traded at $0.58, with a volume of 38,486 shares changing hands.
VolitionRx Trading Down 6.3 %
The firm has a market capitalization of $36.72 million, a PE ratio of -1.04 and a beta of 1.59.
VolitionRx Company Profile
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes.
Read More
- Five stocks we like better than VolitionRx
- 3 Tickers Leading a Meme Stock Revival
- Corporate Crawl: Where Business Trips Turn Into Party Nights?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Investing In Automotive Stocks
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for VolitionRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRx and related companies with MarketBeat.com's FREE daily email newsletter.
